Researchers have identified genetic tests that predict which cancer patients may benefit from the drugs in combination with chemotherapy.
Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of an aggressive form of pancreatic cancer.
UNSW Sydney’s Centre for Molecular Oncology will partner with not-for-profit cancer genomics leader Omico to deliver the national precision oncology program PrOSPeCT.
A new technique developed at the Garvan Institute of Medical Research and UNSW Sydney could make stem cell studies up to 100 times more efficient.
A new study in mice shows that stress can override natural satiety cues and drive cravings for sweet foods.
Fifteen projects have received funding from the Australian Government's Medical Research Future Fund.
Stronger advertising regulations and other weight loss drug options are needed, UNSW Sydney experts say.
Professor John Pimanda receives the new Translational Program Grant for his team’s work with acute myeloid leukaemia.
A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.